January 4, 2017
Bayer nets FDA’s priority review for cancer drug in U.S.
Bayer has started off the new year with another approval from theU.S. Food and Drug Administration (FDA).
Pharmaceuticals, Biotechnology and Life Sciences
Bayer has started off the new year with another approval from theU.S. Food and Drug Administration (FDA).